A detailed history of Centiva Capital, LP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 28,815 shares of RXST stock, worth $469,396. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,815
Holding current value
$469,396
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$24.37 - $35.84 $702,221 - $1.03 Million
28,815 New
28,815 $727,000
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $309,860 - $505,409
8,726 New
8,726 $450,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $450M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.